Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM90A18P encodes a pseudogene within the FAM90A gene family[2][7]. The FAM90A gene family consists of several primate-specific genes and pseudogenes believed to have arisen from gene duplication events[4][6][7]. FAM90A18P itself is classified as a pseudogene and is not known to produce a functional protein product[2][7]. There are no data supporting a role as a therapeutic target, nor established biological function, disease implication, or pharmacology. Gene expression studies may list it as a transcript in some conditions, but current evidence suggests it has no coding or functional role[2][7][9]. The FAM90 family does contain coding genes (e.g., FAM90A1, FAM90A19), but FAM90A18P is annotated only as a noncoding pseudogene variant. Notes on correctness: - The submitted names cluster protein-coding and non-coding pseudogenes together—however, FAM90A18/FAM90A18P is not a confirmed protein-coding gene and does not serve recognized molecular or therapeutic functions[2][7]. - Multiple sources conflate gene names; only FAM90A18P is the standardized HGNC/Ensembl/NCBI name for this pseudogene[2][7]. - No information suggests it acts as a receptor, enzyme, transporter, or has any therapeutic targeting value[2][7]. Summary: FAM90A18P is a pseudogene within the FAM90A family, not a druggable target, and should not be considered a therapeutic receptor, enzyme, or similar molecule. Most references to "Protein FAM90A18" are likely artifacts of gene prediction, not evidence of a functional or druggable protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A18, pseudogene (FAM90A18P).